Inflexion, a leading European mid-market private equity firm, is pleased to announce it has entered an agreement for the sale of its investment in European LifeCare Group (“ELCG”), the largest provider of vaccinations in Europe, to a European private equity group.
European LifeCare Group operates 84 specialist vaccination clinics across Denmark, UK, Netherlands and Sweden providing a range of vaccination services including travel vaccinations, general health vaccinations as well as mass immunisation programmes. For over 20 years, ELCG has been a preferred partner for the delivery of public vaccination programmes for the Danish and UK NHS. In recent years, the company has expanded its services to include supporting vaccine clinical trials for leading pharmaceutical companies, partnering with industry leaders such as Sanofi and Pfizer.
Inflexion supported ELCG’s transformation from a travel vaccination provider into a leading preventative healthcare platform with footprint across Northern Europe. With Inflexion’s backing, ELCG’s management team capitalised on the growing demand for vaccination services, delivering strong organic growth through its direct-to-consumer marketing and trusted reputation with public healthcare systems. Inflexion supported the founder-led succession and strengthened the management team, including key leadership appointments. The business also leveraged Inflexion’s Digital team to enhance its digital marketing strategy.
Under Inflexion’s ownership, ELCG completed four acquisitions and successfully expanded into the Benelux and Swedish markets, nearly tripling its revenue over the period. The number of clinics increased by 65%, the total number of employees grew sixfold, and the total number of vaccinations delivered rose fourteenfold to over 3 million annually.
During our partnership, European LifeCare Group has successfully expanded its geographic footprint across Europe whilst also increasing the range of services that it provides. We would like to thank Tanja and the whole team for their hard work and commitment.
With Inflexion’s support, European LifeCare Group has developed into a truly pan European market leader, and has great prospects for future growth. We wish Tanja and her team all the best for the future as the business continues to expand across Europe.
Inflexion has supported the growth of European LifeCare Group and in particular have provided invaluable insights as we have grown the business through acquisition and entered new geographic markets across Europe. We are proud of what has been achieved with the support of Inflexion and look forward to further growth ahead of us.
The transaction is subject to customary regulatory approvals.
Contact us
Please contact us if you have any media enquiries
